Profile of tezacaftor/ivacaftor combination and its potential in the treatment of cystic fibrosis

Dejene Shiferaw,* Shoaib Faruqi*Department of Respiratory Medicine, Hull University Teaching Hospitals NHS Trust, Cottingham HU16 5JQ, UK *These authors contributed equally to this workCorrespondence: Shoaib FaruqiDepartment of Respiratory Medicine, University of Hull and Hull and York Medical Schoo...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Shiferaw D, Faruqi S
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Dove Medical Press 2019-08-01
Edice:	Therapeutics and Clinical Risk Management
Témata:	Cystic Fibrosis CFTR modulators CFTR potentiators Ivacaftor Tezacaftor triple therapy
On-line přístup:	https://www.dovepress.com/profile-of-tezacaftorivacaftor-combination-and-its-potential-in-the-tr-peer-reviewed-article-TCRM
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!